Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
RESEARCH TOOLSreports
Total Valuation
Hansoh Pharmaceutical Group Company Limited has a market cap or net worth of HK$177.82B. The enterprise value is HK$118.50B.
Market CapHK$177.82B
Enterprise ValueHK$118.50B
Share Statistics
Hansoh Pharmaceutical Group Company Limited has 5,947,150,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,947,150,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hansoh Pharmaceutical Group Company Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 11.94%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)11.94%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.36M
Profits Per Employee486.35K
Employee Count8,989
Asset Turnover0.39
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited is 22.01. Hansoh Pharmaceutical Group Company Limited’s PEG ratio is 1.17.
PE Ratio22.01
PS Ratio0.00
PB Ratio9.72
Price to Fair Value3.36
Price to FCF46.30
Price to Operating Cash Flow38.06
PEG Ratio1.17
Income Statement
In the last 12 months, Hansoh Pharmaceutical Group Company Limited had revenue of 12.26B and earned 4.37B in profits. Earnings per share was 0.74.
Revenue12.26B
Gross Profit11.16B
Operating Income4.03B
Pretax Income5.09B
Net Income4.37B
EBITDA4.25B
Earnings Per Share (EPS)0.74
Cash Flow
In the last 12 months, operating cash flow was 3.86B and capital expenditures -221.96M, giving a free cash flow of 3.64B billion.
Operating Cash Flow3.86B
Free Cash Flow3.64B
Free Cash Flow per Share0.61
Dividends & Yields
Hansoh Pharmaceutical Group Company Limited pays an annual dividend of HK$0.343, resulting in a dividend yield of 1.17%
Dividend Per ShareHK$0.343
Dividend Yield1.17%
Payout Ratio17.55%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change71.33%
50-Day Moving Average24.54
200-Day Moving Average20.24
Relative Strength Index (RSI)70.93
Average Volume (3m)12.05M
Important Dates
Hansoh Pharmaceutical Group Company Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 21, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJul 03, 2025
Financial Position
Hansoh Pharmaceutical Group Company Limited as a current ratio of 10.18, with Debt / Equity ratio of 0.07%
Current Ratio10.18
Quick Ratio9.94
Debt to Market Cap<0.01
Net Debt to EBITDA-5.30
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hansoh Pharmaceutical Group Company Limited has paid 713.36M in taxes.
Income Tax713.36M
Effective Tax Rate0.14
Enterprise Valuation
Hansoh Pharmaceutical Group Company Limited EV to EBITDA ratio is 17.36, with an EV/FCF ratio of 20.26.
EV to Sales6.01
EV to EBITDA17.36
EV to Free Cash Flow20.26
EV to Operating Cash Flow19.09
Balance Sheet
Hansoh Pharmaceutical Group Company Limited has HK$23.39B in cash and marketable securities with ¥117.89M in debt, giving a net cash position of -HK$23.27B billion.
Cash & Marketable SecuritiesHK$23.39B
Total Debt¥117.89M
Net Cash-HK$23.27B
Net Cash Per Share-HK$3.91
Tangible Book Value Per ShareHK$4.79
Margins
Gross margin is 91.51%, with operating margin of 32.88%, and net profit margin of 35.66%.
Gross Margin91.51%
Operating Margin32.88%
Pretax Margin41.48%
Net Profit Margin35.66%
EBITDA Margin34.64%
EBIT Margin31.83%
Analyst Forecast
The average price target for Hansoh Pharmaceutical Group Company Limited is HK$28.14, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$28.14
Price Target Upside-4.29% Downside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast19.29%
EPS Growth Forecast31.35%